|
CL2025003861A1
(es)
|
|
Formulaciones farmacéuticas de un agonista del receptor de amilina y un agonista del receptor de glp-1 que comprenden una ciclodextrina.
|
|
BR102022025291A2
(https=)
|
|
|
|
BR102023014872A2
(https=)
|
|
|
|
BR102023012440A2
(https=)
|
|
|
|
BR102023010976A2
(https=)
|
|
|
|
BR102023009641A2
(https=)
|
|
|
|
BR102023008688A2
(https=)
|
|
|
|
BR102023007252A2
(https=)
|
|
|
|
BR102023005164A2
(https=)
|
|
|
|
BR102023001877A2
(https=)
|
|
|
|
BR102023000289A2
(https=)
|
|
|
|
BR102022026909A2
(https=)
|
|
|
|
BR102022023461A2
(https=)
|
|
|
|
BR202022009269U2
(https=)
|
|
|
|
BY13152U
(https=)
|
|
|
|
CN307048422S
(https=)
|
|
|
|
BY13156U
(https=)
|
|
|
|
CN307045753S
(https=)
|
|
|
|
CN307045483S
(https=)
|
|
|
|
BY13172U
(https=)
|
|
|
|
BY13155U
(https=)
|
|
|
|
CN307044871S
(https=)
|
|
|
|
BY13153U
(https=)
|
|
|
|
CN307044867S
(https=)
|
|
|
|
CN307046084S
(https=)
|
|
|